TARS Dividend History & Analysis | Yield
TARS has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SUPN NASDAQ Supernus Pharmaceuticals |
1,523 M | 28.68% | 67.38% |
| BMY NYSE Bristol-Myers Squibb |
127,020 M | 4.38% | 5.22% |
| TAK NYSE Takeda Pharmaceutical |
67,157 M | 3.83% | 6.03% |
| NVS NYSE Novartis |
305,825 M | 3.06% | 6.98% |
| GSK NYSE GSK |
100,885 M | 3.53% | 5.13% |
| NOVN SW Novartis |
309,130 M | 2.99% | 6.19% |
| VTRS NASDAQ Viatris |
21,789 M | 3.50% | 4.20% |
| MRK NYSE Merck |
362,526 M | 2.89% | 4.72% |
| ORNBV HE Orion |
16,067 M | 2.38% | 5.57% |
| HLUN-B CO H Lundbeck |
8,233 M | 3.08% | 3.50% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
8,233 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
6,295 M | 26.84% | 99.0% |
| FAGR BR Fagron |
1,993 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,215,626 M | 15.25% | 100.0% |
| TUB BR Tubize-Fin |
12,288 M | 9.60% | 100.0% |
| NVS NYSE Novartis |
305,825 M | 8.79% | 100.0% |
| MRK NYSE Merck |
362,526 M | 5.34% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
39,044 M | 5.31% | 100.0% |
| IPN PA Ipsen |
14,410 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
664,947 M | 4.72% | 100.0% |
TARS Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
TARS Dividend FAQ
As of November 2026, TARS's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 73.83.
As of November 2026 TARS does not pay a dividend.
Over the last 12 months, TARS has issued dividend payments.
Based on historical data, the forecasted dividends per share for TARS for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Tarsus Pharmaceuticals (TARS) is currently unknown.
The next Ex-Dividend date for Tarsus Pharmaceuticals (TARS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
TARS's average dividend growth rate over the past 5 years is -% per year.
TARS's 5-Year Yield on Cost is -%. If you bought TARS's shares at 27.19 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
TARS Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
TARS's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of TARS is unknown.
TARS's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
TARS Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-11-03 02:38 UTC